Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2016 Considering Decision Making and Sexuality in Menstrual Suppression of Teens and Young Adults with Intellectual Disabilities Kruti Acharya, MD and John D. Lantos, MD A guardian’s request to sterilize a woman with intellectual disabilities is not ethically justifiable unless the woman assents and it is to her benefit. AMA J Ethics. 2016;18(4):365-372. doi: 10.1001/journalofethics.2016.18.4.ecas2-1604. Policy Forum Mar 2005 Health Care for Incarcerated Adolescents: Significant Needs with Considerable Obstacles Robert E. Morris, MD Virtual Mentor. 2005;7(3):244-248. doi: 10.1001/virtualmentor.2005.7.3.pfor2-0503. State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612. Viewpoint Mar 2005 Teenagers and Cosmetic Surgery Diana Zuckerman, PhD Virtual Mentor. 2005;7(3):253-256. doi: 10.1001/virtualmentor.2005.7.3.oped1-0503. Viewpoint Mar 2005 Ethics of Cosmetic Plastic Surgery in Adolescents Michael A. Bermant, MD Virtual Mentor. 2005;7(3):257-261. doi: 10.1001/virtualmentor.2005.7.3.oped2-0503. Case and Commentary Nov 1999 Who Makes Contraceptive Decisions for Adolescents? Faith Lagay, PhD Virtual Mentor. 1999;1(3):18-. doi: 10.1001/virtualmentor.1999.1.3.hlaw1-9911. Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 1 Melissa D. Colsman, MA and David E. Sandberg, PhD Virtual Mentor. 2005;7(11):727-732. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511. Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 2 David B. Allen, MD Virtual Mentor. 2005;7(11):732-735. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511. Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 3 Wilma C. Rossi, MD, MBe, Virtual Mentor. 2005;7(11):735-738. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary Apr 2016 Considering Decision Making and Sexuality in Menstrual Suppression of Teens and Young Adults with Intellectual Disabilities Kruti Acharya, MD and John D. Lantos, MD A guardian’s request to sterilize a woman with intellectual disabilities is not ethically justifiable unless the woman assents and it is to her benefit. AMA J Ethics. 2016;18(4):365-372. doi: 10.1001/journalofethics.2016.18.4.ecas2-1604.
Policy Forum Mar 2005 Health Care for Incarcerated Adolescents: Significant Needs with Considerable Obstacles Robert E. Morris, MD Virtual Mentor. 2005;7(3):244-248. doi: 10.1001/virtualmentor.2005.7.3.pfor2-0503.
State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612.
Viewpoint Mar 2005 Teenagers and Cosmetic Surgery Diana Zuckerman, PhD Virtual Mentor. 2005;7(3):253-256. doi: 10.1001/virtualmentor.2005.7.3.oped1-0503.
Viewpoint Mar 2005 Ethics of Cosmetic Plastic Surgery in Adolescents Michael A. Bermant, MD Virtual Mentor. 2005;7(3):257-261. doi: 10.1001/virtualmentor.2005.7.3.oped2-0503.
Case and Commentary Nov 1999 Who Makes Contraceptive Decisions for Adolescents? Faith Lagay, PhD Virtual Mentor. 1999;1(3):18-. doi: 10.1001/virtualmentor.1999.1.3.hlaw1-9911.
Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 1 Melissa D. Colsman, MA and David E. Sandberg, PhD Virtual Mentor. 2005;7(11):727-732. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511.
Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 2 David B. Allen, MD Virtual Mentor. 2005;7(11):732-735. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511.
Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 3 Wilma C. Rossi, MD, MBe, Virtual Mentor. 2005;7(11):735-738. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.